It was announced on December 30 that the company received the decision on Issuing warning letter for Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) from Shanghai Securities Regulatory Bureau on December 30, 2021: on September 29, 2020, the company decided to reduce the price of its main product ISEP by 50%. However, the company did not release the announcement on price adjustment of main products until October 22, 2020 to disclose the 50% price reduction of ISEP. The company failed to disclose the price reduction of its main product ISEP in time, in violation of relevant regulations. Shanghai Securities Regulatory Bureau decided to take the supervision and management measures of issuing warning letters to the company.
(interface News)
